- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 327/00 - Acides thiocarboxyliques
Détention brevets de la classe C07C 327/00
Brevets de cette classe: 27
Historique des publications depuis 10 ans
|
1
|
2
|
0
|
1
|
1
|
0
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Massachusetts Institute of Technology | 10131 |
3 |
| Synta Pharmaceuticals Corp. | 173 |
3 |
| Hoffmann-La Roche Inc. | 3511 |
1 |
| President and Fellows of Harvard College | 6017 |
1 |
| Anhui Medical University | 20 |
1 |
| Anhui New Star Pharmaceutical Development Co., Ltd. | 13 |
1 |
| Commonwealth Scientific and Industrial Research Organisation | 1671 |
1 |
| Dana-Farber Cancer Institute, Inc. | 2613 |
1 |
| Eastern Virginia Medical School | 66 |
1 |
| Ecolab USA Inc. | 5559 |
1 |
| Gtx, Inc. | 27 |
1 |
| Isagro S.p.A. | 45 |
1 |
| Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie | 1 |
1 |
| Merial Limited | 113 |
1 |
| North-West University | 57 |
1 |
| Novotyr Therapeutics Ltd. | 4 |
1 |
| Promentis Pharmaceuticals, Inc. | 15 |
1 |
| Vironova Thionation AB | 6 |
1 |
| Washington State University | 488 |
1 |
| Translate bio, Inc. | 416 |
1 |
| Autres propriétaires | 3 |